0001628280-24-026221.txt : 20240603 0001628280-24-026221.hdr.sgml : 20240603 20240603121850 ACCESSION NUMBER: 0001628280-24-026221 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240530 FILED AS OF DATE: 20240603 DATE AS OF CHANGE: 20240603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sigal Charles Elliott CENTRAL INDEX KEY: 0001661908 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39083 FILM NUMBER: 241012747 MAIL ADDRESS: STREET 1: 32 BREARLY ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vir Biotechnology, Inc. CENTRAL INDEX KEY: 0001706431 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 812730369 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1800 OWENS STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-906-4324 MAIL ADDRESS: STREET 1: 1800 OWENS STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 wk-form4_1717431521.xml FORM 4 X0508 4 2024-05-30 0 0001706431 Vir Biotechnology, Inc. VIR 0001661908 Sigal Charles Elliott C/O VIR BIOTECHNOLOGY, INC. 1800 OWENS STREET, SUITE 900 SAN FRANCISCO CA 94158 1 0 0 0 0 Common Stock 2024-05-30 4 A 0 8000 0 A 23806 D Common Stock 10000 I By Sigal Family Investments, LLC Stock Option (Right to Buy) 10.39 2024-05-30 4 A 0 16000 0 A 2025-05-30 2034-05-29 Common Stock 16000 16000 D The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. /s/ Vanina de Verneuil, Attorney-In-Fact 2024-06-03